Stay updated on Cabozantinib for Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe page now includes a dedicated Locations section with the Texas site information and updates the page revision to v3.3.3. The old 'Texas Locations' label and the previous revision v3.3.2 have been removed.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedPublication sourcing language was updated to explain that PubMed publications are automatically filled and may not pertain to the study. The revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page removes a site-wide funding/status notice; the study title, objectives, eligibility, and outcome measures remain unchanged.SummaryDifference0.4%

- Check61 days agoChange DetectedNo additions or deletions detected on the Study Details page (NCT03370718); the page content appears unchanged.SummaryDifference0.4%

- Check83 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check90 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.